ERR pan-agonist. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.
These are long-acting and reach steady state over weeks, so a single day’s timing has little effect. Consistency matters more than the hour.
| When | Dose | How Often | How Many mL | Draw To | Number Of Doses | Peptide Used |
|---|---|---|---|---|---|---|
| Weeks 1–2 | 250 mcg | daily | 0.25 mL | 25 u | 14 | 3.5 mg |
| Week 3 onward per 4 weeks from here on |
500 mcg | daily | 0.5 mL | 50 u | 28 | 14 mg |
| Level | Dose | How Often | How Many mL | Draw To | Doses In Vial |
|---|---|---|---|---|---|
| Research study dose | 50 mg/kg weight-based | daily | Set by body weight — can't be turned into a single amount to draw | ||
| Community reported | 250 mcg | 1× daily | 0.25 mL | 25 u | 20 doses |
| Community reported upper | 500 mcg | 1× daily | 0.5 mL | 50 u | 10 doses |
An estrogen-related receptor pan-agonist described as an exercise mimetic in preclinical models. Not a peptide, no human data of any kind. Reported doses below are the weight-based research figures, given raw rather than converted, because a human-equivalent conversion is not supported.
Buy SLU-PP-332Paid affiliate links.
Adding 5 mL of bacteriostatic water to a 5 mg vial gives 1 mg/mL. That is the mix every number on this page is worked out from — change the water figure in the calculator and all the draw amounts update.
Published and reported figures for SLU-PP-332 run from 250 mcg to 500 mcg, typically 1× daily. This site lists each figure with the source it came from rather than giving a single recommended number.
At 1 mg/mL, a 250 mcg dose is 25 units on a 1 mL U-100 insulin syringe. One vial at that mix gives about 20 doses.
SLU-PP-332 is graded preclinical. Laboratory and animal data only. No human dosing trials have been published. We grade every compound on this site so you can weigh the numbers accordingly — the full method is on our editorial policy page.
Compounds in the same class, or browse the full catalogue.
A small-molecule NNMT inhibitor rather than a true peptide. Research data show reduced adiposity in diet-induced obesity models. D…
Every compound compared in one table: dose range, how often, half-life and evidence tier.
Need this on one page to print, screenshot or send?
Make a dose card →